| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 672521 | 70886 | IRINOTECAN KABI 20 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | IRINOTECAN KABI 20 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 1 vial de 15 ml | 20 mg/ml inyectable 15 ml | 45 | 1 | 34 | 1 vial de 15 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/70886/70886_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/70886/70886_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 14285 | FRESENIUS KABI ESPAÑA, S.A.U. | 2009-05-04 | 1 | 1 | 1 | 2009-05-04 | 2010-08-30 | 1 | 2019-01-31 | View Edit Delete | ||||||||||||
| 672522 | 70886 | IRINOTECAN KABI 20 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | IRINOTECAN KABI 20 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 1 vial de 25 ml | 20 mg/ml inyectable 25 ml | 45 | 1 | 34 | 1 vial de 25 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/70886/70886_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/70886/70886_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 14285 | FRESENIUS KABI ESPAÑA, S.A.U. | 2009-05-04 | 1 | 1 | 1 | 2009-05-04 | 2010-08-30 | 1 | 2019-01-31 | View Edit Delete | ||||||||||||
| 672694 | 47396 | PENILEVEL RETARD 1.000.000 U.I. | PENILEVEL RETARD 1.000.000 U.I. , 1 vial + 1 ampolla de disolvente | 200.000 UI/600.000 UI/200.000 UI | 45 | 1 | 34 | 1 vial + 1 ampolla de disolvente | 0 | 0 | 0 | 0 | No Disponible | No Disponible | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 945 | LABORATORIOS ERN S.A. | 1969-03-01 | 1 | 1 | 1 | 1969-03-01 | 2011-03-29 | 0 | 2011-09-21 | 819177, 653435 | View Edit Delete | |||||||||||
| 672084 | 33411 | GENOXAL 200 mg POLVO PARA SOLUCIÓN INYECTABLE Y PARA PERFUSIÓN | GENOXAL 200 mg POLVO PARA SOLUCIÓN INYECTABLE Y PARA PERFUSIÓN , 1 vial | 200 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/33411/33411_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/33411/33411_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 7980 | BAXTER S.L. | 1960-02-01 | 1 | 1 | 1 | 1960-02-01 | 2011-03-10 | 0 | 2011-07-01 | 876383, 663200 | View Edit Delete | |||||||||||
| 674127 | 96011001 | CAELYX PEGYLATED LIPOSOMAL 2 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION | CAELYX PEGYLATED LIPOSOMAL 2 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 10 ml | 2 mg/ml inyectable 10 ml | 45 | 1 | 34 | 1 vial de 10 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/96011001/96011001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/96011001/96011001_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 30180 | BAXTER S.L. | 1997-07-01 | 1 | 1 | 1 | 1997-07-01 | 1997-07-01 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 673372 | 72609 | CISPLATINO ACCORD 1 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | CISPLATINO ACCORD 1 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG , 1 vial de 10 ml | 1 mg/ml inyectable 10 ml | 45 | 1 | 34 | 1 vial de 10 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72609/72609_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72609/72609_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 11104 | ACCORD HEALTHCARE S.L.U. | 2011-08-11 | 1 | 1 | 1 | 2011-08-11 | 2011-08-11 | 1 | 2012-03-14 | View Edit Delete | ||||||||||||
| 673770 | 72386 | OXALIPLATINO ACCORD 5 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | OXALIPLATINO ACCORD 5 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 1 vial de 40 ml | 5 mg/ml inyectable 40 ml | 45 | 1 | 34 | 1 vial de 40 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72386/72386_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72386/72386_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 11104 | ACCORD HEALTHCARE S.L.U. | 2010-10-01 | 1 | 1 | 1 | 2010-10-01 | 2011-03-16 | 1 | 2011-06-20 | View Edit Delete | ||||||||||||
| 673954 | 63535 | GADOVIST 1 mmol/ml SOLUCION INYECTABLE EN VIAL | GADOVIST 1 mmol/ml SOLUCION INYECTABLE EN VIAL , 1 vial de 15 ml | 1 mmol/ml | 45 | 1 | 34 | 1 vial de 15 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/63535/63535_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/63535/63535_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 11424 | BAYER HISPANIA S.L. | 2001-01-16 | 1 | 1 | 1 | 2001-01-16 | 2001-01-16 | 0 | 2011-10-11 | View Edit Delete | ||||||||||||
| 674119 | 63535 | GADOVIST 1 mmol/ml SOLUCION INYECTABLE EN VIAL | GADOVIST 1 mmol/ml SOLUCION INYECTABLE EN VIAL , 1 vial de 30 ml | 1 mmol/ml | 45 | 1 | 34 | 1 vial de 30 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/63535/63535_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/63535/63535_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 11424 | BAYER HISPANIA S.L. | 2001-01-16 | 1 | 1 | 1 | 2001-01-16 | 2001-01-16 | 0 | 2011-10-11 | View Edit Delete | ||||||||||||
| 672703 | 49313 | BLEOMICINA VIATRIS 15.000 UI (PH EUR) = 15 U (USP) POLVO PARA SOLUCION INYECTABLE | BLEOMICINA VIATRIS 15.000 UI (PH EUR) = 15 U (USP) POLVO PARA SOLUCION INYECTABLE, 1 vial | 15.000 UI | 45 | 1 | 34 | 1 vial | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/49313/49313_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/49313/49313_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 44524 | VIATRIS PHARMACEUTICALS S.L. | 1971-04-01 | 1 | 1 | 1 | 1971-04-01 | 2011-03-29 | 1 | 2011-06-28 | 719542, 754564, 656759 | View Edit Delete | |||||||||||
| 674945 | 62641 | CEFTRIAXONA NORMON 1000 MG POLVO Y SOLUCION PARA SOLUCION INYECTABLE INTRAMUSCULAR EFG | CEFTRIAXONA NORMON 1000 MG POLVO Y SOLUCION PARA SOLUCION INYECTABLE INTRAMUSCULAR EFG, 1 vial + 1 ampolla de disolvente | 1.000 mg | 45 | 1 | 34 | 1 vial + 1 ampolla de disolvente | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/62641/62641_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/62641/62641_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 1999-05-01 | 1 | 1 | 1 | 1999-05-01 | 1999-05-01 | 0 | 2011-10-20 | View Edit Delete | ||||||||||||
| 674952 | 62640 | CEFTRIAXONA NORMON 500 MG POLVO Y SOLUCION PARA SOLUCION INYECTABLE INTRAMUSCULAR EFG | CEFTRIAXONA NORMON 500 MG POLVO Y SOLUCION PARA SOLUCION INYECTABLE INTRAMUSCULAR EFG, 1 vial + 1 ampolla de disolvente | 500 mg | 45 | 1 | 34 | 1 vial + 1 ampolla de disolvente | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/62640/62640_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/62640/62640_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 1999-05-01 | 1 | 1 | 1 | 1999-05-01 | 1999-05-01 | 0 | 2011-10-20 | View Edit Delete | ||||||||||||
| 674960 | 62639 | CEFTRIAXONA NORMON 250 MG POLVO Y SOLUCION PARA SOLUCION INYECTABLE INTRAMUSCULAR EFG | CEFTRIAXONA NORMON 250 MG POLVO Y SOLUCION PARA SOLUCION INYECTABLE INTRAMUSCULAR EFG, 1 vial + 1 ampolla de disolvente | 250 mg | 45 | 1 | 34 | 1 vial + 1 ampolla de disolvente | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/62639/62639_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/62639/62639_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 1999-05-01 | 1 | 1 | 1 | 1999-05-01 | 1999-05-01 | 0 | 2011-10-20 | View Edit Delete | ||||||||||||
| 674994 | 62636 | CEFTRIAXONA NORMON 500 MG POLVO Y DISOLVENTE PARA SOLUCIÓN INYECTABLE Y PARA PERFUSION EFG | CEFTRIAXONA NORMON 500 MG POLVO Y DISOLVENTE PARA SOLUCIÓN INYECTABLE Y PARA PERFUSION EFG, 1 vial + 1 ampolla de disolvente | 500 mg | 45 | 1 | 34 | 1 vial + 1 ampolla de disolvente | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/62636/62636_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/62636/62636_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 1999-05-01 | 1 | 1 | 1 | 1999-05-01 | 1999-05-01 | 0 | 2011-10-20 | View Edit Delete | ||||||||||||
| 672701 | 72877 | INDIO (111 IN) OXINA CURIUM PHARMA SPAIN 37 MBq/ml PRECURSOR RADIOFARMACEUTICO EN SOLUCION | INDIO (111 IN) OXINA CURIUM PHARMA SPAIN 37 MBq/ml PRECURSOR RADIOFARMACEUTICO EN SOLUCION , 1 vial de 37 Mbq en fecha y hora de calibración | 37 MBq/ml | 45 | 1 | 34 | 1 vial de 37 Mbq en fecha y hora de calibración | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72877/72877_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72877/72877_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 28969 | CURIUM PHARMA SPAIN S.A. | 2010-10-15 | 1 | 1 | 1 | 2010-10-15 | 2010-10-15 | 1 | 2012-10-05 | View Edit Delete | ||||||||||||
| 672136 | 08463001 | RELISTOR 12 mg/0,6 ml, SOLUCION INYECTABLE | RELISTOR 12 mg/0,6 ml, SOLUCION INYECTABLE, 1 vial de 0,6 ml | 12 mg | 45 | 1 | 34 | 1 vial de 0,6 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/08463001/08463001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/08463001/08463001_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 30213 | ZENTIVA SPAIN S.L. | 2009-01-09 | 1 | 1 | 1 | 2009-01-09 | 2011-03-28 | 1 | 2012-03-22 | 662079 | View Edit Delete | |||||||||||
| 673413 | 72635 | DOCETAXEL AUROVITAS 20 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION | DOCETAXEL AUROVITAS 20 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION , 1 vial de 4 ml | 20 mg/ml inyectable 4 ml | 45 | 1 | 34 | 1 vial de 4 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72635/72635_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72635/72635_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 38359 | AUROVITAS SPAIN, S.A.U. | 2011-01-10 | 1 | 1 | 1 | 2011-01-10 | 2011-01-10 | 1 | 2011-07-26 | View Edit Delete | ||||||||||||
| 673414 | 72635 | DOCETAXEL AUROVITAS 20 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION | DOCETAXEL AUROVITAS 20 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION , 1 vial de 7 ml | 20 mg/ml inyectable 7 ml | 45 | 1 | 34 | 1 vial de 7 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72635/72635_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72635/72635_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 38359 | AUROVITAS SPAIN, S.A.U. | 2011-01-10 | 1 | 1 | 1 | 2011-01-10 | 2011-01-10 | 1 | 2011-07-26 | View Edit Delete | ||||||||||||
| 673037 | 06337011 | M-M-RVAXPRO POLVO Y DISOLVENTE PARA SUSPENSION INYECTABLE EN JERINGA PRECARGADA | M-M-RVAXPRO POLVO Y DISOLVENTE PARA SUSPENSION INYECTABLE EN JERINGA PRECARGADA, 1 vial + 1 jeringa precargada de disolvente | N/A (vacuna) | 45 | 1 | 34 | 1 vial + 1 jeringa precargada de disolvente | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/06337011/06337011_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/06337011/06337011_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34945 | MERCK SHARP & DOHME DE ESPANA S.A. | 2006-06-06 | 1 | 1 | 1 | 2006-06-06 | 2011-06-20 | 1 | 2011-10-05 | 654487, 663210 | View Edit Delete | |||||||||||
| 674741 | 72725 | RIASTAP 1 G POLVO PARA SOLUCION INYECTABLE O PERFUSION | RIASTAP 1 G POLVO PARA SOLUCION INYECTABLE O PERFUSION, 1 vial | 1.000 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72725/72725_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72725/72725_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 27753 | CSL BEHRING S.A. | 2011-03-08 | 1 | 1 | 1 | 2011-03-08 | 2011-03-08 | 1 | 2012-05-03 | View Edit Delete |
Page 22 of 1036, showing 20 records out of 20709 total, starting on record 421, ending on 440